Methods for evaluating endothelial function: A position statement from the European Society of Cardiology Working Group on Peripheral Circulation

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 6, 2011, Pages 775-789

  Lekakis, John ^a   Abraham, Pierre ^b   Balbarini, Alberto ^c   Blann, Andrew ^d   Boulanger, Chantal M ^e   Cockcroft, John ^f   Cosentino, Francesco ^g   Deanfield, John ^h   Gallino, Augusto ⁱ   Ikonomidis, Ignatios ^a   Kremastinos, Dimitrios ^a   Landmesser, Ulf ^j   Protogerou, Athanase ^a   Stefanadis, Christodoulos ^a   Tousoulis, Dimitris ^a   Vassalli, Giuseppe ⁱ   Vink, Hans ^k   Werner, Nikos ^l   Wilkinson, Ian ^m   Vlachopoulos, Charalambos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ OSPEDALE SAN GIOVANNI   (Switzerland)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l UNIVERSITY HOSPITAL BONN   (Germany)

^m ADDENBROOKE S HOSPITAL   (United Kingdom)

more..

Author keywords

Biomarkers; Cell derived microparticles; Coronary angiography; Endothelium; Glycocalyx; Laser Doppler flowmetry; Nitric oxide; Plethysmography; Progenitor cells; Pulse

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PADGEM PROTEIN; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

BIOASSAY; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL FUNCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENDOTHELIUM FUNCTION; EPICARDIUM; GLYCOCALYX; HUMAN; LASER DOPPLER FLOWMETRY; MEDICAL SOCIETY; METHODOLOGY; OBESITY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PULSE WAVE; REVIEW; TONOMETRY; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; CARDIOLOGY; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ENDOTHELIUM, VASCULAR; EUROPE; HEMODYNAMICS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SOCIETIES, MEDICAL;

EID: 84855203002     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826711398179     Document Type: Review

References (109)

1. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315(17): 1046-1051. (Pubitemid 17170620)
2. Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotar-olimus-versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 2009; 53(18): 1653-1659.
3. Husmann L, Gaemperli O, Schepis T, Scheffel H, Valenta I, Hoefflinghaus T, et al. Accuracy of quantitative coronary angiography with computed tomography and its dependency on plaque composition: plaque composition and accuracy of cardiac ct. Int J Cardiovasc Imaging 2008; 24(8): 895-904.
4. Terashima M, Nguyen PK, Rubin GD, Iribarren C, Courtney BK, Go AS, et al. Impaired coronary vasodila-tion by magnetic resonance angiography is associated with advanced coronary artery calcification. JACC Cardiovasc Imaging 2008; 1(2): 167-173. (Pubitemid 351445399)
5. Di Mario C, Heyndrickx GR, Prati F and Pijls NH. Chapter 8: Invasive imaging and haemodynamics. In: Camm AJ, Luscher TF, Serruys PW and European Society of Cardiology (eds) The ESC textbook of cardiovascular medicine, 2nd ed. Oxford, New York: Oxford University Press, 2009, p.xxiv, 1398 pp.
6. Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, et al. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans. Eur J Nucl Med Mol Imaging 2007; 34(1): 20-27. (Pubitemid 44885550)
7. Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 2002; 105(21): 2482-2486. (Pubitemid 34568968)
8. Aarnoudse W, Van't Veer M, Pijls NH, Ter Woorst J, Vercauteren S, Tonino P, et al. Direct volumetric blood flow measurement in coronary arteries by thermodilu-tion. J Am Coll Cardiol 2007; 50(24): 2294-2304. (Pubitemid 350192107)
9. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106(6): 653-658. (Pubitemid 34851922)
10. Targonski PV, Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR and Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebro-vascular events. Circulation 2003; 107(22): 2805-2809. (Pubitemid 36705990)
11. Vassalli G, Gallino A, Kiowski W, Jiang Z, Turina M and Hess OM. Reduced coronary flow reserve during exercise in cardiac transplant recipients. Circulation 1997; 95(3): 607-613. (Pubitemid 27063036)
12. Joyner MJ, Dietz NM and Shepherd JT. From belfast to mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J Appl Physiol 2001; 91(6): 2431-2441. (Pubitemid 33108001)
13. Whitney RJ. The measurement of volume changes in human limbs. J Physiol 1953; 121(1): 1-27.
14. Hokanson DE, Sumner DS and Strandness Jr DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975; 22(1): 25-29.
15. Panza JA, Quyyumi AA, Brush Jr JE and Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323(1): 22-27. (Pubitemid 20209468)
16. Chowienczyk PJ, Watts GF, Cockcroft JR and Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340(8833): 1430-1432.
17. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104(2): 191-196. (Pubitemid 32655837)
18. Heitzer T, Schlinzig T, Krohn K, Meinertz T and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104(22): 2673-2678. (Pubitemid 33108132)
19. Fichtlscherer S, Breuer S and Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "Vulnerable" patient. Circulation 2004; 110(14): 1926-1932. (Pubitemid 39331903)
20. Pohl U, Holtz J, Busse R and Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986; 8(1): 37-44. (Pubitemid 16161419)
21. Anderson EA and Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 1989; 79(1): 93-100. (Pubitemid 19043679)
22. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholestero-lemia. Circ Res 2001; 88(2): 145-151. (Pubitemid 32147301)
23. Leeson P, Thorne S, Donald A, Mullen M, Clarkson P and Deanfield J. Non-invasive measurement of endothe-lial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997; 78(1): 22-27. (Pubitemid 27346876)
24. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002; 39(2): 257-265. (Pubitemid 34084631)
25. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995; 74(3): 247-253.
26. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008; 51(20): 1959-1964. (Pubitemid 351636449)
27. Celermajer DS, Sorensen KE, Bull C, Robinson J and Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24(6): 1468-1474. (Pubitemid 24344241)
28. Halcox JP, Donald AE, Ellins E, Witte DR, Shipley MJ, Brunner EJ, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009; 119(7): 1005-1012.
29. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes Jr DR and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothe-lial dysfunction. Circulation 2000; 101(9): 948-954. (Pubitemid 30131694)
30. Alexopoulos N, Vlachopoulos C, Aznaouridis K, Baou K, Vasiliadou C, Pietri P, et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 2008; 15(3): 300-305.
31. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004; 109(16): 1981-1986. (Pubitemid 38544488)
32. Wilkinson IB and McEniery CM. Arterial stiffness, endothelial function and novel pharmacological approaches. Clin Exp Pharmacol Physiol 2004; 31(11): 795-799. (Pubitemid 39556856)
33. Nichols WW, Denardo SJ, Wilkinson IB, McEniery CM, Cockcroft J and O'Rourke MF. Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich) 2008; 10(4): 295-303.
34. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11(2): 138-144. (Pubitemid 20095698)
35. Wilkinson IB, MacCallum H, Cockcroft JR and Webb DJ. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002; 53(2): 189-192. (Pubitemid 34264274)
36. Klemsdal TO, Andersson TL, Matz J, Ferns GA, Gjesdal K and Anggard EE. Vitamin E restores endothelium dependent vasodilatation in cholesterol fed rabbits: in vivo measurements by photoplethysmography. Cardiovasc Res 1994; 28(9): 1397-1402. (Pubitemid 24300445)
37. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type ii diabetes mellitus. J Am Coll Cardiol 1999; 34(7): 2007-2014. (Pubitemid 30002658)
38. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22(1): 147-152. (Pubitemid 34076246)
39. Hayward CS, Kraidly M, Webb CM and Collins P. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 2002; 40(3): 521-528. (Pubitemid 34833170)
40. Kals J, Kampus P, Kals M, Pulges A, Teesalu R and Zilmer M. Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease. Atherosclerosis 2006; 185(2): 368-374.
41. Wallberg-Jonsson S, Caidahl K, Klintland N, Nyberg G and Rantapaa-Dahlqvist S. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. Scand J Rheumatol 2008; 37(1): 1-5.
42. Lind L, Fors N, Hall J, Marttala K and Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the prospective investigation of the vasculature in uppsala seniors (pivus) study. Arterioscler Thromb Vasc Biol 2005; 25(11): 2368-2375. (Pubitemid 41552656)
43. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146(1): 168-174. (Pubitemid 36851317)
44. Noon JP, Haynes WG, Webb DJ and Shore AC. Local inhibition of nitric oxide generation in man reduces blood flow in finger pulp but not in hand dorsum skin. J Physiol 1996; 490(Pt 2): 501-508. (Pubitemid 26032963)
45. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D and Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101(2): 545-548. (Pubitemid 44162364)
46. Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR, Kuvin JT and Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44(11): 2137-2141. (Pubitemid 39576032)
47. de Jongh RT, Serne EH, IJzerman RG, de Vries G and Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109(21): 2529-2535. (Pubitemid 38720552)
48. Mitchell GF, Vita JA, Larson MG, Parise H, Keyes MJ, Warner E, et al. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the framingham heart study. Circulation 2005; 112(24): 3722-3728. (Pubitemid 43739512)
49. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, et al. (-)-epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006; 103(4): 1024-1029. (Pubitemid 43212215)
50. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31(9): 1142-1148.
51. Gush RJ and King TA. Discrimination of capillary and arterio-venular blood flow in skin by laser doppler flow-metry. Med Biol Eng Comput 1991; 29(4): 387-392.
52. Khan F, Patterson D, Belch JJ, Hirata K and Lang CC. Relationship between peripheral and coronary function using laser doppler imaging and transthoracic echocar-diography. Clin Sci (Lond) 2008; 115(9): 295-300.
53. Fredriksson I, Larsson M and Stromberg T. Measurement depth and volume in laser doppler flowme-try. Microvasc Res 2009; 78(1): 4-13.
54. Ozbebit FY, Esen F, Gulec S and Esen H. Evaluation of forearm microvascular blood flow regulation by laser doppler flowmetry, iontophoresis, and curve analysis: contribution of axon reflex. Microvasc Res 2004; 67(3): 207-214. (Pubitemid 38581873)
55. Durand S, Tartas M, Bouye P, Koitka A, Saumet JL and Abraham P. Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans. J Physiol 2004; 561(Pt 3): 811-819. (Pubitemid 40074936)
56. Norman M and Martin H. Preterm birth attenuates association between low birth weight and endothelial dysfunction. Circulation 2003; 108(8): 996-1001. (Pubitemid 37048231)
57. Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet JL, et al. Microvascular endothelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Med 2009; 10(7): 746-752.
58. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48(9): 1856-1862. (Pubitemid 29415208)
59. Khan F, Elhadd TA, Greene SA and Belch JJ. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 2000; 23(2): 215-220. (Pubitemid 30071027)
60. Andreassen AK, Gullestad L, Holm T, Simonsen S and Kvernebo K. Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients. Clin Transplant 1998; 12(4): 324-332. (Pubitemid 28306597)
61. Abularrage CJ, Sidawy AN, Aidinian G, Singh N, Weiswasser JM and Arora S. Evaluation of the microcir-culation in vascular disease. J Vasc Surg 2005; 42(3): 574-581.
62. Kubli S, Feihl F and Waeber B. Beta-blockade with nebi-volol enhances the acetylcholine-induced cutaneous vaso-dilation. Clin Pharmacol Ther 2001; 69(4): 238-244. (Pubitemid 32382506)
63. Rossi M, Carpi A, Di Maria C, Franzoni F, Galetta F and Santoro G. Skin blood flowmotion and microvascu-lar reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res 2009; 58(1): 39-47.
64. Settergren M, Pernow J, Brismar K, Jorneskog G and Kalani M. Endothelin-a receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. J Vasc Res 2008; 45(4): 295-302. (Pubitemid 351793732)
65. Vallance P, Leone A, Calver A, Collier J and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339(8793): 572-575.
66. Iribarren C, Husson G, Sydow K, Wang BY, Sidney S and Cooke JP. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the cardia study. Eur J Cardiovasc Prev Rehabil 2007; 14(2): 222-229. (Pubitemid 46650077)
67. Juonala M, Viikari JS, Alfthan G, Marniemi J, Kahonen M, Taittonen L, et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young finns study. Circulation 2007; 116(12): 1367-1373. (Pubitemid 47417562)
68. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the atherogene study. Circ Res 2005; 97(5): e53-59.
69. Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, et al. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in gothenburg. Arterioscler Thromb Vasc Biol 2008; 28(5): 961-967. (Pubitemid 351544114)
70. Boger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylargi-nine and incidence of cardiovascular disease and death in the community. Circulation 2009; 119(12): 1592-1600.
71. Tsimikas S. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol 2008; 101(10A): 34D-42D.
72. Meisinger C, Baumert J, Khuseyinova N, Loewel H and Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005; 112(5): 651-657. (Pubitemid 41099043)
73. Wu T, Willett WC, Rifai N, Shai I, Manson JE and Rimm EB. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4e6, an independent predictor of coronary heart disease among US. men and women? J Am Coll Cardiol 2006; 48(5): 973-979. (Pubitemid 44292442)
74. Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010; 121(1): 110-122.
75. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002; 23(22): 1764-1770. (Pubitemid 35334269)
76. Hugel B, Martinez MC, Kunzelmann C and Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005; 20: 22-27. (Pubitemid 40363367)
77. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM and Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335(1): 143-151.
78. Wang JM, Wang Y, Huang JY, Yang Z, Chen L, Wang LC, et al. C-reactive protein-induced endothelial micro-particle generation in huvecs is related to bh4-dependent no formation. J Vasc Res 2007; 44(3): 241-248. (Pubitemid 46597306)
79. Boulanger CM, Amabile N, Guerin AP, Pannier B, Leroyer AS, Mallat CN, et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2007; 49(4): 902-908. (Pubitemid 351664206)
80. Boulanger CM, Amabile N and Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48(2): 180-186. (Pubitemid 44309805)
81. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16(11): 3381-3388. (Pubitemid 46179341)
82. Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR, et al. Endothelial microparti-cles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007; 19(2): 161-166. (Pubitemid 46340832)
83. Esposito K, Ciotola M, Schisano B, Gualdiero R, Sardelli L, Misso L, et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 2006; 91(9): 3676-3679. (Pubitemid 44402155)
84. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101(8): 841-843. (Pubitemid 30117876)
85. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, et al. Elevated levels of ve-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45(10): 1622-1630. (Pubitemid 40704497)
86. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145(6): 962-970. (Pubitemid 36688245)
87. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177(11): 1268-1275. (Pubitemid 351860937)
88. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothe-lial dysfunction. Circulation 2001; 104(22): 2649-2652. (Pubitemid 33108128)
89. Schwartz SM and Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 1976; 73(2): 651-653.
90. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85(3): 221-228. (Pubitemid 29377293)
91. Duda DG, Cohen KS, Scadden DT and Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2(4): 805-810. (Pubitemid 46745577)
92. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109(5): 1801-1809. (Pubitemid 46348173)
93. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111(22): 2981-2987. (Pubitemid 40814192)
94. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. Hmg-coa reductase inhibitors (statins) increase endothelial progenitor cells via the pi 3-kinase/akt pathway. J Clin Invest 2001; 108(3): 391-397. (Pubitemid 32730785)
95. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348(7): 593-600. (Pubitemid 36204953)
96. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353(10): 999-1007. (Pubitemid 41262334)
97. Jung C, Rafnsson A, Shemyakin A, Bohm F and Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010; 143(3): 368-372.
98. Desai A, Glaser A, Liu D, Raghavachari N, Blum A, Zalos G, et al. Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 2009; 29(1): 121-127.
99. Erbs S, Linke A, Schachinger V, Assmus B, Thiele H, Diederich KW, et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the doppler substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (repair-ami) trial. Circulation 2007; 116(4): 366-374. (Pubitemid 47196542)
100. Ikonomidis I, Papadimitriou C, Vamvakou G, Katsichti P, Venetsanou K, Stamatelopoulos K, et al. Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function. Growth Factors 2008; 26(3): 117-124. (Pubitemid 351911393)
101. van den Berg BM, Nieuwdorp M, Stroes ES and Vink H: Glycocalyx and endothelial (dys) function: from mice to men. Pharmacol Rep 2006; 58 (Suppl): 75-80.
102. Van Teeffelen JW, Brands J, Jansen C, Spaan JA and Vink H. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice. Hypertension 2007; 50(1): 261-267. (Pubitemid 46986050)
103. Bruegger D, Rehm M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, et al. Exogenous nitric oxide requires an endothelial glycocalyx to prevent post-ischemic coronary vascular leak in guinea pig hearts. Crit Care 2008; 12(3): R73.
104. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 2003; 100(4): 1885-1890. (Pubitemid 36254543)
105. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55(2): 480-486. (Pubitemid 43343279)
106. Nieuwdorp M, Meuwese MC, Mooij HL, van Lieshout MH, Hayden A, Levi M, et al. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 2009; 202(1): 296-303.
107. Nieuwdorp M, Holleman F, de Groot E, Vink H, Gort J, Kontush A, et al. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia 2007; 50(6): 1288-1293. (Pubitemid 46701566)
108. Meuwese MC, Mooij HL, Nieuwdorp M, van Lith B, Marck R, Vink H, et al. Partial recovery of the endothe-lial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. J Lipid Res 2009; 50(1): 148-153.
109. Romanens M, Ackermann F, Spence JD, Darioli R, Rodondi N, Corti R,et al. Improvementof cardiovascular risk prediction: Time to review current knowledge, debates, and fundamentals on how to assess test characteristics. Eur J Cardiovasc Prev Rehabil 2010; 17(1): 18-23.